Probing for affective side effects of drugs used in geriatric practice: Use of daily diaries to test for effects of metoclopramide and naproxen

Neuropsychopharmacology

Volumn 30, Issue 8, 2005, Pages 1568-1575

  Katz, Ira R ^a,b   Morales, Knashawn ^a   Datto, Catherine ^a,b   Streim, Joel ^a,b   Oslin, David ^a,b   DiFilippo, Suzanne ^a   Ten Have, Thomas ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Affect; Daily diaries; Metoclopramide; Mood disorders; Naproxen; Randomized clinical trial

Indexed keywords

METOCLOPRAMIDE; NAPROXEN;

AGED; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; EMOTIONAL DISORDER; FEMALE; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MOOD; PRIORITY JOURNAL;

AFFECT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COGNITION; DOPAMINE ANTAGONISTS; DOUBLE-BLIND METHOD; GERIATRIC ASSESSMENT; HUMANS; MEDICAL RECORDS; METOCLOPRAMIDE; MIDDLE AGED; MOOD DISORDERS; NAPROXEN;

EID: 23844496150     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300751     Document Type: Article

References (30)

1. Anfinson TJ (2002). Akathisia, panic, agoraphobia, and major depression following brief exposure to metoclopramide. Psychopharmacol Bull 36: 82-93.
2. Browning CH (1996). Nonsteroidal anti-inflammatory drugs and severe psychiatric side effects. Int J Psychiatry Med 26: 25-34.
3. Carpay J, Schoenen J, Ahmad F, Kinrade F, Boswell D (2004). Efficacy and tolerability of sumatriptan tablets in a fast-disintegrating, rapid-release formulation for the acute treatment of migraine: results of a multicenter, randomized, placebo-controlled study. Clin Ther 26: 214-223.
4. Diggle PJ, Liang KY, Zeger SL (1994). Analysis of Longitudinal Data. Oxford University Press: New York.
5. Fahn S, Elton RL, Members of the UPDRS Development Committee (1987). Unified Parkinson's Disease Rating Scale in Recent Developments. In: Fahn S, Marsden CD, Calne DB et al (eds). Parkinson's Disease. Macmillan Health Care Information: Florham Park, NJ. pp 153-163.
6. Freeman EW, DeRubeis RJ, Rickels K (1996). Reliability and validity of a daily diary for premenstrual syndrome. Psychiatry Res 65: 97-106.
7. Friend KD, Young RC (1997). Late-onset major depression with delusions after metoclopramide treatment. Am J Geriatr Psychiatry 5: 79-82.
8. Furlan PM, Kallan MJ, TenHave T, Lucki I, Katz IR (2004). SSRIs do not cause affective blunting in healthy elderly volunteers. Am J Geriatr Psychiatry 12: 323-330.
9. Jiang H-K, Chang D-M (1999). Non-steroidal anti-inflammatory drugs with adverse psychiatric reactions: five case reports. Clin Rheumatol 18: 339-345.
10. Kleban MH, Lawton MP, Nesselroade JR, Parmelee P (1992). The structure of variation in affect among depressed and nondepressed elders. J Gerontol 47: P190-198.
11. Lawton MP, De Voe MR, Parmelee P (1995a). Relationship of events and affect in the daily life of an elderly population. Psychol Aging 10: 469-477.
12. Lawton MP, Kleban MH, Dean J (1993). Affect and age: cross-sectional comparisons of structure and prevalence. Psychol Aging 8: 165-175.
13. Lawton MP, Kleban MH, Dean J, Rajagopal D, Parmelee PA (1992a). The factorial generality of brief positive and negative affect measures. J Gerontol 47: 228-237.
14. Lawton MP, Kleban MH, Rajagopal D, Dean J (1992b). Dimensions of affective experience in three age groups. Psychol Aging 7: 171-184.
15. Lawton MP, Parmelee PA, Katz IR, Nesselroade J (1996). Affective states in normal and depressed older people. J Gerontol Psychol Sci 51B: 309-316.
16. Lawton MP, Winter L, Kleban MH, Ruckdeschel K (1995b). Affect and quality of life: objective and subjective. J Aging Health 11: 169-198.
17. Lepola U, Arato M, Zhu Y, Austin C (2003). Sertraline versus imipramine treatment of comorbid panic disorder and major depressive disorder. J Clin Psychiatry 64: 654-662.
18. Marin RS, Biedrzycki RC, Firinciogullari S (1991). Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res 38: 143-162.
19. Masters JC, O'Grady M (1995). Adverse reactions to metoclopramide (Reglan) presenting as depression in a bone marrow transplant patient. Med Surg Nurs 4: 481-485.
20. Parmelee PA, Katz IR, Lawton MP (1989). Depression among institutionalized aged: assessment and prevalence estimation. J Gerontol 44: M22-29.
21. PDR (2004). Physicians' Desk Reference Companion Guide. Medical Economics: Montvale, NJ.
22. Radloff LS (1977). The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1: 385-401.
23. Santanello NC, Barber BL, Reiss TF, Friedman BS, Juniper EF, Zhang J (1997). Measurement characteristics of two asthma symptom diary scales for use in clinical trials. Eur Resp J 10: 646-651.
24. Scharer LO, Hartweg V, Hoern M, Graesslin Y, Strobl N, Frey S et al (2002). Electronic diary for bipolar patients. Neuropsychobiology 46(Suppl 1): 10-12.
25. Schwartz JE, Stone AA (1998). Strategies for analyzing ecological momentary assessment data. Health Psychol 17: 6-16.
26. Stone AA (2000). The Science of Self-Report. Mahwah, NJ: Lawrence Erlbaum.
27. Stone AA, Shiffman S, Schwartz JE, Broderick JE, Hufford MR (2003). Patient compliance with paper and electronic diaries. Controlled Clin Trials 24: 182-199.
28. Sublette ME, Russ MJ, Smith GS (2004). Evidence for a role of the arachidonic acid cascade in affective disorders: a review. Bipolar Disord 6: 95-105.
29. Weddington Jr WW, Banner A (1986). Organic affective syndrome associated with metoclopramide: case report. J Clin Psychiatry 47: 208-209.
30. Winter L, Lawton MP, Casten RJ, Sando RL (2000). The relationship between external events and affect states in older people. Int J Aging Hum Dev 50: 85-96.